Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC

Condition:   Esophageal Cancer
Interventions:   Drug: SHR-1210;   Radiation: IMRT or VMAT;   Drug: Apatinib
Sponsors:   Tianjin Medical University Cancer Institute and Hospital;   Jiangsu HengRui Medicine Co., Ltd.
Not yet recruiting

https://ift.tt/2MvyUNv